Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Halozyme Downgraded at Piper Sandler Despite Guidance Raise
Citigroup Adjusts Price Target on Johnson & Johnson to $180 From $185, Keeps Buy Rating
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ)
Johnson & Johnson Analyst Ratings
Johnson & Johnson (JNJ) Receives a Buy From RBC Capital
Johnson & Johnson Analyst Ratings
Redburn Atlantic Adjusts Johnson & Johnson Price Target to $160 From $170
Neurocrine Biosciences Upgraded at Wells Fargo on Pipeline
Johnson & Johnson Analyst Ratings
HSBC Upgrades Johnson & Johnson to Buy, Raises Price Target to $170
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ)